Yurt Dışı Yayınlar

CV-Cagatay Taskiran
Name: Cagatay Taskiran
Birth date: 01.01.1974
Birth place: Anamur
Nationality: T.C.
Education:
Years
Institute
Medical Faculty
Residency
Assoc.Prof.
Hacettepe University, Faculty of Medicine
Hacettepe University, Faculty of Medicine, Department
of OB/GYN
OB/GYN
Subspeciality
Gynecologic oncological surgery
June 1997
March 2002
December
2007
June 2011
Institutes:
Years
Institute
Resident
Specialist
Assist. Prof.
Assist. Prof.
Assoc.Prof.
Assoc.Prof.
Hacettepe University, Faculty of Medicine, Department
of OB/GYN
Hacettepe University, Faculty of Medicine, Department
of OB/GYN
Hacettepe University, Faculty of Medicine, Department
of OB/GYN
Gazi University, Faculty of Medicine, Department of
OB/GYN
Gazi University, Faculty of Medicine, Department of
OB/GYN
VKV American Hospital
October 1997March 2002
March 2002October 2002
October 2002June 2003
June20032007
2007-2011
2011-
Scientific Society Memeberships: European Society of Gynecologic Oncology.
International Gynecologic Cancer Society
Türk Jinekolojik Onkoloji Derneği
Jinekolojik Endoskopi Derneği
Scientific Society Membership of Executive Board
Turkish Society of Gynecologic Endoscopy
PUBLICATIONS
A. International Journals
(SCI and SCIE):
A1. C. Taskiran, Erdem, O., Onan, A., Arisoy, O., Acar, A., Vural, C., Erdem, M., Ataoglu,
O. ve Guner, H., “The prognostic value of endoglin (CD105) expression in ovarian carcinoma,”
Int. J. Gynecol. Cancer, 16, 1789-93 (2006).
A2. Onan, MA., C. Taskiran, Bozdayi, G., Biri, A., Erdem, O., Acar, A., Gunaydin, G., Rota,
S., Ataoglu, O., ve Guner, H., “Assessment of human papilloma viral load of archival cervical
intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population,” Eu.r
J. Gynaecol. Oncol., 26, 632-5 (2005).
A3. C. Taskiran, Aktas, D., Yigit-Celik, N., Alikasifoglu, M., Yuce, K., Tuncbilek, E. ve
Ayhan, A., “CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia
and invasive cervical cancer,” Gynecol. Oncol., 101, 503-6 (2006).
A4. C. Taskiran, Baltaci, V. ve Gunalp, S., “A rare spermatogenic disorder, globozoospermia:
is there a role for Y chromosome microdeletions?,” J. Reprod. Med., 51, 628-634 (2006).
A5. C. Taskiran, Erdem, O., Onan, A., Bozkurt, N., Yaman-Tunc, S., Ataoglu, O. ve Guner,
H., “The role of frozen section evaluation in the diagnosis of adnexal mass,” Int. J. Gynecol.
Cancer, 18, 235-40 (2008).
A6. Erdem, O., C. Taskiran, Onan, M.A., Erdem, M., Guner, H. ve Ataoglu, O., “CD105
expression is an independent predictor of survival in patients with endometrial cancer,”
Gynecol. Oncol., 103, 1007-11 (2006).
A7. Ayhan, A., Bozdag, G., C. Taskiran, Gultekin, M., Yuce, K. ve Kucukali, T., “The value
of preoperative platelet count in the prediction of cervical involvement and poor prognostic
variables in patients with endometrial carcinoma,” Gynecol. Oncol., 103, 902-5 (2006).
A8. Onan, M.A., Turp, A.B., C. Taskiran, Ozogul, C. ve Himmetoglu, O., “Spontaneous
closure of the hymen during pregnancy,” Am. J. Obstet. Gynecol., 193, 889-91 (2005).
A9. Taner, M.Z., C. Taskiran, Onan, M.A., Gursoy, R. ve Himmetoglu, O., “Therapeutic
value of trichloroacetic acid in the treatment of isolated genital warts of the external genitalia”.
Journal of Reprod Med, 52, 521-5 (2007).
A10. Taner, M.Z., C. Taskiran, Onan, M.A., Uluturk, A. ve Himmetoglu, O., “Genital human
papillomavirus infection in the male sexual partners of women with isolated vulvar lesions,”
Int. J. Gynecol. Cancer, 16, 791-4 (2006).
A11. C. Taskiran, Yuce, K., Ozdemir-Geyik, P., Kucukali, T. ve Ayhan, A., “Predictability of
retroperitoneal lymph node metastasis by using clinico-pathological variables in surgically
staged endometrial cancer,” Int. J. Gynecol. Cancer, 16, 1342-7 (2006). (tezden üretilmiştir)
A12. Ayhan, A., Gultekin, M., C. Taskiran, Dursun, P., Firat, P., Bozdag, G., Yigit-Celik, N.
ve Yuce, K., “Ascites and epithelial ovarian cancers: a reapraisal with respect to different
aspects,” Int. J. Gynecol. Cancer, 17, 68-75 (2007).
A13. Ayhan, A., Gultekin, M., Yigit-Celik, N., Dursun, P., C. Taskiran, Aksan, G. ve Yuce,
K., “Occult metastasis in early ovarian cancers: risk factors and associated prognosis,” Am. J.
Obstet. Gynecol., 196, 81.e1-81.e6 (2007).
A14. Ayhan, A., C. Taskiran, Yigit-Celik, N., Gultekin, M., Tuncer, S., Guler, N. ve Yuce, K.,
“Topotecan as a second-line therapy in patients with ovarian and primary peritoneal cancer:
initial response and long-term follow-up,” Eur. J. Gynaecol. Oncol., 27, 603-6 (2006).
A15. Onan, M.A., Turp, A.B., Saltik, A, Akyurek, N., C. Taskiran ve Himmetoglu, O.,
“Primary omental pregnancy: case report,” Hum. Reprod., 20, 807-9 (2005).
A16. Taner, M.Z., Ozpolat, E., C. Taskiran, Onan, M.A., Gursel, T., Karabulut, E., Gursoy, R.
ve Himmetoglu, O., “Effects of four different regimens of hormone replacement therapy on
hemostatic parameters: a prospective randomized study,” Maturitas, 53, 267-73 (2006).
A17. Ayhan, A., C. Taskiran, Yigit-Celik, N., Bozdag, G., Gultekin, M., Usubutun, A., Guler,
N. ve Yuce, K., “Long-term survival after paclitaxel plus platinum-based combination
chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that
for ovarian serous papillary cancer?,” Int. J. Gynecol. Cancer, 16, 484-9 (2006).
A18. Ayhan, A., C. Taskiran, Simsek, S. ve Sever, A., “Does immediate hormone replacement
therapy affect the oncologic outcome in endometrial cancer survivors?,” Int. J. Gynecol.
Cancer, 16, 805-8 (2006).
A19. Ayhan, A., Gultekin, M., C. Taskiran, Aksan, G., Celik, N.Y., Dursun, P., Salman, M.C.,
Yuce, K. ve Kucukali, T., “The role of secondary cytoreduction in the treatment of ovarian
cancer: Hacettepe University experience,” Am. J. Obstet. Gynecol., 194, 49-56 (2006).
A20. Ayhan, A., C. Taskiran, Celik, C. ve Yuce, K., “The long-term survival of women with
surgical stage II endometrioid type endometrial cancer,” Gynecol. Oncol., 93, 9-13 (2004).
A21. Dursun, P., Salman, M.C., C. Taskiran, Yuce, K. ve Ayhan, A., “Retroperitoneal
leiomyomatosis: a case report,” Int. J. Gynecol. Cancer, 15, 1222-5 (2005).
A22. Ayhan, A., C. Taskiran, Bozdag, G., Altinbas, S., Altinbas, A. ve Yuce, K.,
“Endodermal sinus tumor of the ovary: the Hacettepe University experience,” Eur. J. Obstet.
Gynecol. Reprod. Biol., 123, 230-4 (2005).
A23. Ayhan, A., Gultekin, M., C. Taskiran, Celik, N.Y., Usubutun, A., Kucukali, T. ve Yuce,
K., “Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological
variables,” Gynecol. Oncol., 97, 400-4 (2005).
A24. Ayhan, A., Gultekin, M., C. Taskiran, Salman, M.C., Celik, N.Y., Yuce, K., Usubutun,
A. ve Kucukali, T., “Routine appendectomy in epithelial ovarian carcinoma: is it necessary?”
Obstet. Gynecol., 105, 719-24 (2005).
A25. Dursun, P., Salman, M.C., C. Taskiran, Usubutun, A. ve Ayhan, A., “Primary
neuroendocrine carcinoma of the fallopian tube: a case report,” Am. J. Obstet. Gynecol., 190,
568-71 (2004).
A26. Ozcakar, L., Kara, M., Erol, M., Kaymak, B., Akinci, A., C. Taskiran ve Ayhan, A., “A
reappraisal on the management of lumbosacral plexopathies in gynecological malignancies:
where do the physiatrists stand?” Int. J. Gynecol. Cancer, 15, 915-7 (2005).
A27. Ayhan, A., C. Taskiran, Celik, C., Guney, I., Yuce, K., Ozyar, E., Atahan, L. ve
Kucukalı, T., “Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I
endometrial cancer?,” Gynecol. Oncol., 86, 259-263 (2002).
A28. Ayhan, A., C. Taskiran, Celik, C., Yuce, K. ve Kucukali, T., “The influence of
cytoreductive surgery on survival and morbidity in Stage IVB endometrial cancer,” Int. J.
Gynec. Cancer, 2, 448-53 (2002).
A29. Ayhan, A., C. Taskiran, Celik, C., Yuce, K. ve Aksu, T., “Surgical stage III endometrial
cancer: analysis of treatment outcomes, prognostic factors and failure patterns,” Eur. J.
Gynaecol. Oncol., 23, 553-6 (2002).
A30. Ayhan, A., C. Taskiran, Yuce, K. ve Kucukali, T., “The prognostic value of nuclear and
the revised International Federation of Gynecology and Obstetrics grading of endometrial
adenocarcinoma,” Int. J. Gynecol. Pathol., 22, 71-4 (2003).
A31. Ayhan, A., Celik, H., C. Taskiran, Bozdag, G. ve Aksu, T., “Oncologic and therapeutic
outcome after fertility-saving surgery in ovarian cancer,” Eur. J. Gynaecol. Oncol., 24, 223-32
(2003).
A32. Ayhan, A., Guney, I., Saygan-Karamursel, B. ve C. Taskiran., “Ovarian metastasis of
primary biliary and gallbladder carcinomas,” Eur. J. Gynaecol. Oncol., 22, 377-8 (2001).
A33. Baykal, C., Baykal, Y., C. Taskiran, Esinler, I., Demirol, A., Doğan, R. ve Ayhan, A.,
“An extraordinary case of four primary tumors in the same patient, involving uterine cervix,
lung, skin, and rectum,” Eur. J. Gynaecol. Oncol., 23, 451-2 (2002).
A34.Atalay, F., C. Taskiran, Taner, M.Z., Pak, I., Or, M., Tuncer, S. “Detection of human
Papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma.” J. Obstet.
Gynaecol. Res. 33, 823-8 (2007).
A35.Turkyilmaz, E., Korucuoglu, U., Kutlusoy, F., Efeturk, T., Dogan, H.T., Onan, A., Guner,
H., C. Taskiran. “Recurrent mucinous cystadenoma: a laparoscopic approach.” Arch. Gynecol.
Obstet., 279, 387-9 (2009).
A36. Dinc B, Rota S, Onan A, Bozdayı G, Taskiran C, Biri A, Güner H. Prevalence of
human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with
several cervical pathologies Braz J Infect Dis Jan-Feb 14(1): 19-23, 2010.
A37. Onan A, Özkan S, Korucuoglu Ü, Aksakal N, Taşkıran Ç, Aygün R, Güner H,
Knowledge on and Attitude Toward Human Papillomavirus Infection and its Vaccine in a
Turkish Subpopulation. Türkiye Klinikleri Journal of Medicine 29(3), 594-598, 2009.
A38. Onan MA, Taskıran Ç, Karabacak O, Açar A, Korucuoglu Ü, Tıras MB, Retrospective
Analysis of Laparoscopically Treated Cases of Tubo-Ovarian Abscess, Turkiye Klinikleri
Journal of Medicine, 29(4), 872-6, 2009.
A39. Turkish Cervical Cancer and Cervical Cytology Research Group,Prevalance of Cervical
cytological abnormalities in Turkey,International Journal of Gynaecology and Obstetrics
2009, 106(3), 206-209.
Journals except for SCIE:
A40. Esinler, I., Guven, S., Akyol, D., Guvendag Guven, E.S., C. Taskiran ve Ayhan, A.,
“Abdominal wall endometriosis without previous surgery,” J. Obstet. Gynaecol., 24, 931
(2004).
A41.Yildirim, M., Bozkurt, N., Kurdoglu, M., C. Taskiran, Oktem, M., Dilek, K.U.
“Histopathologic findings in women with postmenopausal bleeding: implication for
endometrial thickness and circulating levels of sex steroid hormones.” Arch. Gynecol. Obstet.
276, 305-10 (2007).
A42.Taner, M.Z., Kurdoglu, M., C. Taskiran, Onan, M.A., Gunaydin, G., ve Himmetoglu, O.
“Prenatal diagnosis of achondrogenesis type I: a case report” Cases J., 18, 406 (2008).
B. Abstracts Presented at International Meetings
B1. Taskiran, C., A.Onan, O. Arisoy, F. Kutlusoy, A. Acar, B. Tiras, H. Guner, ve O.
Karabacak. “Laparoscopic management of adnexal masses”. 11th Biennial International
Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.
B2. Taskiran, C., O. Erdem, A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O. Ataoglu, H.
Guner. “The prognostic value of endoglın (cd105) expressıon ın epıthelıal ovarıan cancer”.
11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa
Monica, USA, 2006.
B3. Taskiran, C., A. Onan, O. Erdem, F. Kandemir, F. Kutlusoy, O. Ataoglu, H. Guner.
“Distribution of cervical preinvasive diseases in Turkısh population after Bethesda III at
tertiary referral center”. 11th Biennial International Gynecologic Cancer Society Meeting
(IGCS), October 14-18, Santa Monica, USA, 2006.
B4. Taskiran, C., A. Onan, S. Yaman-Tunc, O. Erdem, O. Ataoglu, H. Guner. “The predictive
value of frozen section diagnosis in ovarian masses treated by laparotomy”. 11th Biennial
International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica,
USA, 2006.
B5. Taskiran, C., O. Erdem, A. Onan, O. Ataoglu, H. Guner. “What is the importance of
immunohistochemically determined lymphovascular space involvement in epithelial ovarian
cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 1418, Santa Monica, USA, 2006.
B6. Taskiran, C., A. Onan, H. Guner. “Early postoperative oral intake after surgery for
gynecological cancer including systematic lymphadenectomy”. 11th Biennial International
Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.
B7. Taskiran, C., N. Karabacak, A. Onan, E. Demir, O. Arisoy, T. Atasever, H. Guner. “The
value of pet-ct in the follow-up of patients with ovarian cancer”. 11th Biennial International
Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.
B8. Taskiran, C., O. Erdem, A. Onan, O. Ataoglu, H. Guner. “The accuracy of intraoperative
assessment of peritoneal washing cytology”. 11th Biennial International Gynecologic Cancer
Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.
B9. Taskiran, C., A. Onan, P. Ozcan, H. Guner. “Toxicity of docetaxel plus carboplatin
combination chemotherapy in the first-line treatment of ovarian cancer”. 11th Biennial
International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica,
USA, 2006.
B10. A. Onan, Taskiran, C., G. Gunaydin, E. Demir, A. Bedirli, H. Guner. “Colonic surgery in
patients with ovarian cancer”. 11th Biennial International Gynecologic Cancer Society
Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.
B11. A.Onan, Taskiran, C., O. Arisoy, A. Acar, O. Erdem, O. Ataoglu, H. Guner. “What is
the final pathology of patients who have endometrial hyperplasia at D&C and subjected to the
hysterectomy”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS),
October 14-18, Santa Monica, USA, 2006.
B12. H. Guner, O. Erdem, Taskiran, C., A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O.
Ataoglu. “The role of angiogenesis determined by CD31 in epıthelial ovarian cancer”. 11th
Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa
Monica, USA, 2006.
B13. H. Guner, O. Erdem, Taskiran, C., A. Onan, O. Ataoglu. “The role of lymphovascular
space involvement assessed by hematoxilen&eosin in patients with epithelial ovarian cancer”.
11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa
Monica, USA, 2006.
B14. A. Erdem, Taskiran C., E. Biberoglu, K. Biberoglu. The effect of hormone replacement
therapy on serum copper levels. 7th European Congress on Menopause, 3-7 June, 2006.
B15. A. Erdem, Taskiran C., E. Biberoglu, K. Biberoglu. The effect of hormone replacement
therapy on homocysteine levels. 7th European Congress on Menopause, 3-7 June, 2006.
B16. M. Gultekin, P. Dursun, T. Guler, S. Esin, N.Y. Calik, Taskiran, C., K. Yuce, A. Ayhan.
“Pre-operative Ca-125 levels: correlation with clinico-pathologic factors”. ESGO 14, İstanbul,
Türkiye, 2005.
B17. G. Bozdag, Taskiran C., M. Gultekin, P. Dursun, K. Yuce, A. Ayhan. “The predictive
value of preoperative Ca 125 level for lymph node metastasis and clinicopathologic features
among endometrium cancer patients”. ESGO 14, İstanbul, Türkiye, 2005.
B18. G. Bozdag, Taskiran C., M. Gultekin, P. Dursun, K. Yuce, A. Ayhan. “The preoperative
platelet count is higher in endometrium cancer patients with the advanced stage and high
grade”. ESGO 14, İstanbul, Türkiye, 2005.
B19. Taskiran, C., A. Onan, A. Acar, B. Ciftci, H. Guner ve O. Karabacak, “What is The
Percentage of Malignancies In Patients Treated with Laparoscopy For Benign Adnexial Mass?”
10th Biennial International Gynecologic Cancer Society Meeting (IGCS), Edinburg, İskoçya,
2004.
B20. O. Erdem, Taskiran, C., A. Onan, H. Guner, M. Erdem ve O. Ataoglu, “The Prognostic
Role of Angiogenetic Factors In Endometrial Cancer,” 10th Biennial International Gynecologic
Cancer Society Meeting (IGCS), Edinburg, İskoçya, 2004.
B21. M.A. Onan, Taskiran, C., A. Bedirli, G. Gunaydin, B. Mentes ve H. Guner, “Necessity
of Gastrointestinal Surgical Procedures(GSP) In Ovarian Cancer Debulking,” 10th Biennial
International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004.
B22. M.A. Onan, Taskiran, C., G. Bozdayi, O. Erdem, S. Rota ve H. Guner, “Assessment of
Human Papilloma Viral Load By Real-Time Polymerase Chain Reaction (RT-PCR) In Cervical
Intraepithelial Neoplasia,” 10th Biennial International Gynecologic Cancer Society
Meeting(IGCS), Edinburg, İskoçya, 2004.
B23. N.Y. Celik, M. Gultekin, Taskiran, C., P. Dursun, M.C. Salman, S. Esin, G. Aksan, A.
Usubutun, T. Kucukali, K. Yuce ve A. Ayhan, “Recurrences following a negative SLL in
patient with epithelial ovarian carcinoma,” 10th Biennial International Gynecologic Cancer
Society Meeting(IGCS), Edinburg, İskoçya, 2004.
B24. P. Dursun, M. Gultekin, N.Y. Celik, Taskiran, C., A. Parlakgumus, G. Aksan, S. Esin ve
A. Usubutun, “Comparison of clinico-pathologic and survival characteristics of epithelial
ovarian carcinoma with respect to age,” 10th Biennial International Gynecologic Cancer
Society Meeting(IGCS), Edinburg, İskoçya, 2004.
B25. M. Gultekin, N.Y. Celik, Taskiran, C., P.Dursun, S. Esin, G. Aksan, G. Bozdag, A.
Usubutun, T. Kucukali, K. Yuce ve A. Ayhan, “Upstaging in epithelial ovarian carcinoma,”
10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya,
2004.
B26. Taskiran, C., K. Yuce ve A. Ayhan, “Predictibility of retroperitoneal lymph node
metastasis in endometrial cancer,” ESGO 13, Brüksel, Belçika, 2003 (Sözlü sunum).
B27. Taskiran, C., K. Yuce ve A. Ayhan, “The role of surgical staging for high risk stage I
and stage II endometrial cancer without adjuvant radiotherapy,” ESGO 13, Brüksel, Belçika,
2003 (Sözlü sunum).
B28. Taskiran, C., S. Simsek, A. Sever, Z. Yıldırım ve A. Ayhan, “Immediate hormone
replacement therapy in endometrial cancer survivors,” ESGO 13, Brüksel, Belçika, 2003 (Sözlü
sunum).
B29. Taskiran, C., N. Yigit, S. Tuncer, K. Yuce ve A. Ayhan, “Topotecan in the second-line
and third-line treatment of ovarian cancer,” ESGO 13, Brüksel, Belçika., 2003.
B30. I. Esinler, S. Kumru,Taskiran, C., K. Yuce ve A. Ayhan, “Cervical intraepithelial
neoplasia: Hacettepe experience,” ESGO 13, Brüksel, Belçika., 2003.
B31. Taskiran, C., N. Yigit, K. Yuce ve A. Ayhan, “Primary peritoneal serous papillary
carcinoma: Hacettepe experience,” ESGO 13, Brüksel, Belçika., 2003.
B32. Taskiran, C., S. Guvendag, FC, K. Yuce ve A. Ayhan, “Borderline epithelial ovarian
neoplasia: Hacettepe experience,” ESGO 13, Brüksel, Belçika, 2003.
B33. G. Bozdag, A. Basaran, A. Kızılkılıç, Taskiran, C., K. Yuce ve A. Ayhan, “Fertilitysaving surgery for malignant and borderline ovarian tumors,” ESGO 13, Brüksel, Belçika.,
2003.
B34. G. Bozdag, Taskiran, C., H. Yarali ve A. Ayhan, “Pregnancy after intracytoplasmic
sperm injection in a patient with stage I endometrial carcinoma treated with fertility-saving
surgery and progestins,” ESGO 13, Brüksel, Belçika, 2003.
B35. G. Mocan, P. Fırat, B. Can, Taskiran, C., ve S. Tuncer, “ASCUS and AGUS-Close
follow up is necessary,” 28th European Congress of Cytology, Antwerp, Belçika, 2002.
B36. Taskiran, C., A. Altınbas, S. Kiziltas, A. Ayhan ve K. Yuce, “Endodermal sinus tumor of
the ovary: The Hacettepe Experience,” 9th Biennial meeting of IGCS (International
Gynecologic Cancer Society), Seul, Kore, 2002 (Sözlü sunum).
B37. Taskiran, C., B. Peynircioglu, D. Akata, M. Ozmen, O. Akhan ve A. Ayhan,
“Comparison of US, CT, and MRI in the prospective evaluation of peritoneal carcinomatosis,”
9th Biennial meeting of IGCS, Seul, Kore, 2002.
B38. Taskiran, C., S. Guvendag, S. Guven, H. Yuksel, K. Yuce ve Ali Ayhan, “Vulvar
dystrophy: an evaluation of 795 cases,” 9th Biennial meeting of IGCS, Seul, Kore, 2002.
B39. A. Ayhan, Taskiran, C., K. Yuce ve T. Kuçukali, “The prognostic value of nuclear grade
in endometrial cancer,” ESGO 12 (The European Society of Gynecologic Oncology), Venedik,
İtalya, 2001 (Oral presentation).
B40. Taskiran, C., M. Basaran, K. Yuce, Z.S. Tuncer ve A. Ayhan, “Prognostic factors
predicting retroperitoneal lymph node metastasis in endometrial carcinoma,” ESGO 12 (The
European Society of Gynecologic Oncology), Venedik, İtalya, 2001 (Oral presentation) .
B41. Taskiran, C., C. Celik, K. Yuce ve A. Ayhan, “Optimal cytoreductive surgery is an
independent prognostic indicator in stage IV endometrial cancer,” ESGO, Venedik, İtalya,
2001.
B42. A. Ayhan, Taskiran, C., I. Guney, S. Tuncer, C. Celik, L. Atahan, E. Ozyar, K. Yuce ve
T. Kuçukali, “Prognostic factors in surgical stage I endometrial cancer,” 8th biennial meeting of
IGCS, Buenos Aires, Arjantin, 2000.
B43. A. Ayhan, Taskiran, C., I. Guney, C. Celik, K. Yuce, E. Karabulut ve T. Kucukali,
“Radical hysterectomy without radiotherapy in surgical stage II endometrial cancer,” 8th
biennial meeting of IGCS, Buenos Aires, Arjantin, 2000.
B44. Taskiran, C., I. Guney., C. Celik, K. Yuce, T. Kuçukali ve A. Ayhan, “Surgical stage III
and IV endometrial cancer: a study of 75 cases,” 8th biennial meeting of IGCS, Buenos Aires,
Arjantin, 2000.
B45. Taskiran C, Erdem O, Onan A, Bozkurt N, Vural C, Arisoy O, Atraoglu O, Guner H,
Maspin expression in endometrial hyperplasia and carcinoma and relation with angiogenesis.
15thInternational Meeting of the ESGO , Jin.Onkoloji , Berlin-Almanya , 2007.
B46. Guner H, Erdem O, Korucuoglu U, Onan A, Vural C, Taskiran C. Maspin expression in
patients with cervical intraepithelial neoplasia and cervical cancer. 15thInternational Meeting
of the ESGO , Jin.Onkoloji , Berlin-Almanya , 2007.
B47. Taskiran C, Erdem O, Onan A, Korucuoglu U,Ataoglu O, Guner H. The prognostic
importance of lymphovascular space involvement determined by both Hematoxilen & Eosin
and immunohistochemical techniques in patients with epithelial ovarian cancer. 15th
International Meeting of the ESGO , Jin.Onkoloji , Berlin -Almanya , 2007.
B48. Onan A, Taskiran C, Bedirli A, Turkyılmaz E, Guner H. The value of colon resection in
patients with epithelial ovarian cancer. 15th International Meeting of the ESGO , Jin.Onkoloji ,
Berlin -Almanya , 2007.
B49.A. Onan, A. Acar, I. Fidan, C. Taskiran, S. Rota, R. Gursoy, H. Guner. Human papilloma
virus positivity in patients with abnormal cervical cytology. 12th Biennial Meeting of
International Gynecologic Cancer Society 2008.
B50.A. Onan, S. Ozkan, U. Korucuoglu, N. Aksakal, C. Taskiran, R. Aygun, H. Guner.
Knowledge on and attitude toward human papillomavirus infection and its vaccine in a Turkish
subpopulatıon. 12th Biennial Meeting of International Gynecologic Cancer Society 2008.
B51.B. Dinc, A. Onan, G. Bozdayi, C. Taskiran, S. Rota, H. Guner. Prevalance and
genotyping of human papillomavirus (HPV) by in house and real-time pcr in patients with
several cervical pathologies. 12th Biennial Meeting of International Gynecologic Cancer
Society 2008.
B52.H. Guner, A. Onan, S. Tunc, I. Fidan, S. Rota, C. Taskiran. The prevalance of human
papilloma virus infections in Turkey. 12th Biennial Meeting of International Gynecologic
Cancer Society 2008.
B53.C. Taskiran, A. Onan, A. Bedirli, U. Korucuoglu, E. Turkyilmaz, H. Guner. Partial
gastrectomy to achieve optimal cytoreduction in ovarian cancer. 12th Biennial Meeting of
International Gynecologic Cancer Society 2008.
B54.C. Taskiran, A. Onan, E. Turkyilmaz, U. Korucuoglu, A. Bedirli, H. Guner.
Diaphragmatic resection by using unipolar cautery for patients wıth ovarian cancer. 12th
Biennial Meeting of International Gynecologic Cancer Society 2008.
B55.H. Guner, C. Taskiran, F. Atalay, U. Korucuoglu, O. Erdem, B. Celtemen, G. Barıt, I.
Pak, A. Onan. The survival benefit of lymphatic dissection on survival in patients with
endometrial cancer. 12th Biennial Meeting of International Gynecologic Cancer Society 2008.
B56.C. Taskiran, F. Atalay, A. Onan, U. Korucuoglu, B. Celtemen, G. Barıt, I. Pak, O. Erdem,
H. Guner. What should be the minimum resected lymph node number to detect lymphatic
metastasis in endometrial cancer. 12th Biennial Meeting of International Gynecologic Cancer
Society 2008. (Oral presentation)
B57. Taskıran C, Onan A, Turkyılmaz E, Kerem M, Bedirli A, Guner H.Significant
improvement in optimal surgery for epithelial ovarian cancer by ultraradical operations. 16th
International Meeting of the European Society of Gynaecological Oncology ESGO ,
Jinekolojik Onkoloji , Belgrad-Sırbistan , 2009.
B58. Onan A, Yaman Tunc S, Taskiran C, Fidan I, Ozkan S, Rota S, Guner H. The prevalance
of HPV infection in Turkish population. 16th International Meeting of the European Society of
Gynaecological Oncology ESGO , Jinekolojik Onkoloji , Belgrad-Sırbistan , 2009.
B59. Guner H, Taskiran C, Onan A, Turkyılmaz E, Kerem M, Erdem O, Bedirli A.Mesocolon
lymph node positivity in patients with colon resection for gynecologic malignancy. 16th
International Meeting of the European Society of Gynaecological Oncology ESGO ,
Jinekolojik Onkoloji , Belgrad-Sırbıstan , 2009.
B60. Onan MA, Tunc SY, Korun ZE, Taskiran C, Ozışık MS, Fidan I, Rota S, Guner H. HPV
subtypes in patients with cytological abnormalities in Gazi University Outpatient Clinic. 13th
Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010, Prague, Czech
Republic, 2010.
B61. Onan MA, Tunc SY, Ozisik MS, Taskıran C, Korun ZE, Fidan I, Rota S, Gıner H. The
prevalance of HPV infection in Gazi University Outpatient Clinic. 13th Biennial Meeting of the
International Gynecologic Cancer Society-IGCS 2010, Prague, Czech Republic, 2010.
B62. Türk Jinekolojik Onkoloji Grubu. HPV prevalance in Turkey: A Multicenter Turkish
Gynecologic Oncology Group Study. 13th Biennial Meeting of the International Gynecologic
Cancer Society-IGCS 2010, Prague, Czech Republic, 2010.
B63. Güner H, Cakıcı C, Onan A, Taskiran C, Turkyılmaz E, Buyrukcu BA, Ustun H.
Comparison of cervical smear results recieved by doctors and recieved by cervix self-smear test
kit. 13th Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010,
Prague, Czech Republic, 2010.
D. Publications at National Journals:
D1. Tıraş, M.B., Ç. Taşkıran, Onan, A., Dilek,T.U.K., Biri, A., Bozkurt, N. and Güner H.,
“The success rate of Burch procedure when it is performed with laparoscopic total
hysterectomy,” Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, 111-5, (2005).
D2. Tıraş, M.B., Ç. Taşkıran, Onan, A., Odabaşı, A.R., Dilek, U.K. and Güner, H.,
“Evaluation of 30 cases of total laparoscopic hysterectomy,” Türkiye Klinikleri Jinekoloji
Obstetrik Dergisi, 15, 116-122, (2005).
D3. Tıraş, B. and Ç. Taşkıran, “treatment options during postmenopausal osteoporosis,”
Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, özel sayı 1, 21-31, (2005).
D4. Ç. Taşkıran, Başaran, A. ve Günalp G. S., “Globozoospermia: the last point at male
infertility,” Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, 273-9, (2005).
D5. Salman, M.C., Gültekin, M., Ç. Taşkıran ve Ayhan, A.,. “Hormones and breast,” Türk
Jinekolojik Onkoloji Dergisi, 8, 37-53, (2005).
D6. Ç. Taşkıran, Açar, A., Yılmaz, E., Onan, A., Tunç, L., Ataoğlu, Ö., Güner, H.
Retroperitoneal and intraabdominal malignant fibrous histiocytoma: case report. Türk
Jinekolojik Onkoloji Dergisi, 8, 111-114, (2005).
D7. Taner, M.Z., Akçin, Ü., Ç. Taşkıran, Onan, A., Önder, M. ve Himmetoğlu, Ö.,
“Congenital Syphilis as a Cause of Hydrops Fetalis in a Woman With Spyhilis Incognito,” J.
Turkish German Gynecol. Assoc., 5, 318-20, (2004).
D8. Yılmaz, G., Erdem, Ö., Onan, A., Ç. Taşkıran ve Ataoğlu, Ö., “Sex cord stromal elements
within endometrial stromal sarcoma,” Türk jinekolojik onkoloji dergisi, 7, 83-87, (2004).
D9. Bozkurt, N., Arısoy, Ö., Ç. Taşkıran, Kutlusoy, F., Kurdoglu, Z., Himmetoğlu Ö. “MPV
values of patients with gestational hypertension and preeclampsia”. Türk fertilite dergisi, 14,
209-12, (2006).
D10. Bozkurt, N., Korucuoglu, U., Arisoy, Ö., Ç. Taşkıran, Himmetoğlu Ö. “The mean
platelet volume in subjects with intrauterine growth retardation”. Türk fertilite dergisi, 14, 21316, (2006).
D11. Güner, H., Ç. Taşkıran. “Epidemiology of cervical cancer and HPV”. Uzmanlık sonrası
eğitim ve güncel gelişmeler dergisi, 4, 11-19, (2007).
D12. Ç. Taşkıran, Kurdoğlu, M., Bozkurt, N., Polat, M., Kurdoğlu, Z., Yıldırım, M. “The
effect of uterine myomas on hematological parameters”. Türk fertilite dergisi, 14, 195-99,
(2006).
D13. Yılmaz E., Onan A., Ç. Taşkıran, Günaydın G., Güler İ., Korucuoğlu Ü., Güner H.
“Vaginal aggressive angiomixoma: case report”. Türk jinekolojik onkoloji dergisi 9, 50-53
(2006).
D14. Ç. Taşkıran, Yılmaz E., Onan A., Güner H. “The value of surgical staging in cervical
cancer”. Türk jinekolojik onkoloji dergisi 9, 27-34 (2006).
D15.Guner H., Yılmaz E., Ç.Taşkıran. The value of neoadjuvant chemotherapy in ovarian
cancer. Türkiye Klinikleri J Surg Med Sci, 3, 70-76, (2007).
D16.Yılmaz E., Ç. Taşkıran, Tıraş B., Guner H., Karabacak O. Experience of simple
hysterectomy at tertiary university clinic. TJOD Dergisi, 5, 195-201, (2008).
Editor or editorial board memebership at national books:
Gynecologic Oncology, Editor: Ali Ayhan Editorial board: Polat Dursun, Murat Gültekin,
Çağatay Taşkıran; Güneş Kitabevi, 2013.
Chapter in International Book
Cagatay Taskiran, Anıl Onan, Haldun Guner. Role of retroperitoneal lymphatic debulking in
gynecologic cancers. Textbook of Gynecological Oncology, ESGO, 2nd Edition. Editors:
Ayhan, Reed, Gultekin, Dursun.
a-Chapter in National books:
Fa1. Taşkıran, Ç., “Uterine Sarcomas”. Kadın Hastalıkları ve Doğum Bilgisi, ed. N. Çiçek, C.
Akyürek, Ç. Çelik ve A. Haberal, 2. Baskı, 1211-1219, Güneş Kitabevi, 2006.
Fa2. L. Önderoğlu, B. S. Karamürsel ve Taşkıran, Ç., “Cesarean”, Jinekolojik ve Obstetrikal
Cerrahi, ed. H. Güner, 1549-1581, Güneş Kitabevi, 2005.
Fa3. A. Yıldız, ve Taşkıran Ç. “Non-immün hidrops fetalis”. Temel Kadın Hastalıkları ve
Doğum Bilgisi. Ed. A. Ayhan, T. Durukan, S. Günalp, T. Gürgan, L. Önderoğlu, K. Yüce.
Güneş Kitabevi.
Fa4. Taşkıran Ç., ve H. Güner. “Vaginal hysterectomy”. Ürojinekoloji ve pelvik rekonstrüktif
cerrahi. Ed. H. Güner. Güneş Kitabevi, 333-342.
Fa5. Taşkıran Ç., ve Ü. Korucuoğlu. Bengin diseases of ovary and tube. Klinikte obstetrik ve
jinekoloji. Ed. Nedim Çiçek ve Tamer Mungan. Güneş Kitabevi, 2007.
Fa6. Taşkıran, Ç., E. Yılmaz. Upper abdominal cytoreductive surgery. Jinekolojik Cerrahi,
ed. H. Güner, Güneş Kitabevi, 2011.
Fa7. Taşkıran, Ç., Surgery at early stage endometrial cancer. Jinekolojik Onkoloji, Editör: Ali
Ayhan Editör Yardımcıları: Polat Dursun, Murat Gültekin, Çağatay Taşkıran; Güneş Kitabevi,
2013.
Fa8. Ercan Yılmaz, Taşkıran, Ç., Endometrial cancer. Temel Kadın Hastalıkları ve Doğum
Bilgisi, 3. Baskı, Güneş Kitabevi.
Editorial board membership at book translated from original English version
Danfort’s Obstetrics and Gynecology. Editor: Ali Ayhan Editorial board: Çağatay Taşkıran,
Polat Dursun. Güneş Kitabevi.
b-Chapter in books translated from original English version
Fb1. Rifat Gürsoy, Çağatay Taşkıran. Hormonal status. Bölüm 30. Reproductive
Endocrinology. Ed.: Yen & Jaffe. Çeviri Ed.: Serdar Günalp. Güneş Kitabevi, sayfa: 939-964,
2006.
Fb2. Çağatay Taşkıran ve Übeyt Akçin. Psychiatric problems. Novak Jinekoloji. 13. Baskı.
Çeviri Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 323-351, 2004.
Fb3.Rifat Gürsoy, Çağatay Taşkıran. Amenorrhea. Novak Jinekoloji. 13. Baskı. Çeviri
Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 843-871, 2004.
Fb4. Rifat Gürsoy, Çağatay Taşkıran. Endometriosis. Novak Jinekoloji. 13. Baskı. Çeviri
Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 931-973, 2004.
Fb5. Çağatay Taşkıran. Treatment of ascites and intestinal obstruction at terminal patient.
Jinekolojik Kanserler-Tartışmalı Konular ve Çözümleriyle. Ed. Prof.Dr.Z.Selçuk Tuncer.
Gynecologic Cancer: Controversies in Management, Ed. Gershenson DM, McGuire WP, Gore
M, Quinn MA, Thomas G. Sayfa 727-741, 2004.
Fb6. Sezin Yüce, Kunter Yüce, Çağatay Taşkıran. Germ cell, stromal and other tumors.
Klinik Jinekolojik Onkoloji, Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, Ed., DıSaıa,
Creasman. Sayfa 351-375, 2003.
Fb7. Ali Ayhan, Çağatay Taşkıran. Endometrial hyperplasia/Estrogen treatment. Klinik
Jinekolojik Onkoloji. Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa,
Creasman. Sayfa 113-136, 2003.
Fb8. Çağatay Taşkıran. GOG toxicity criteria. Klinik Jinekolojik Onkoloji, (ekler). Ed., Dr.
Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 621-624,
2003.
Fb9. Çağatay Taşkıran. Cancer screening. Klinik Jinekolojik Onkoloji, (ekler). Ed., Dr. Ali
Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 633-634, 2003.
Fb10. Çağatay Taşkıran. Statistical analysis. Klinik Jinekolojik Onkoloji, (ekler), Ed., Dr. Ali
Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 629-632, 2003.
Fb11. Çağatay Taşkıran. Are endometrial stromal tumors responsive to hormones?HRT ve
Kanser. Güneş Kitabevi. Hormone Replacement Therapy and Cancer, Ed., A.R. Genazzani,
148-154, 2003.
Fb12. Çağatay Taşkıran. Breast diseases. Benson&Pernoll Obstetrik ve Jinekoloji El Kitabı,
Editör: Prof.Dr. Ali Ayhan, Dr. Gürkan Bozdağ, Palme Yayıncılık, 547-570, 2002.
Fb13. Çağatay Taşkıran. Vulvar and vaginal diseases. Benson&Pernoll Obstetrik ve
Jinekoloji El Kitabı, Editör: Prof.Dr. Ali Ayhan, Dr. Gürkan Bozdağ, Palme Yayıncılık, 571598, 2002.
Fb14. Çağatay Taşkıran ve Baran Celtemen. “Malignanat diseases of hematologic and
immunologic systems”. High risk pregnancies. Yüksek riskli gebelikler. Ed. Haldun Güner.
Güneş Kitabevi, 889-900.
d-Certificates.
Fd1. USMLE Step 1, October 1997; ve USMLE Step 2, March 1998.
e-Organization of National Congress or Course
Fe1. Congress secretary. 10. National congress of Gynecologic Oncology. 19-23 Nisan 2006,
Antalya.
Fe2. Secretary. Video-workshop in gynecologic oncology. 12-14 Şubat 2009, Ankara.
Fe3. Course director. Video workshop in gynecologic oncology, precongress course, animal
lab. 2011, Ankara.
f-Lectures at National Meetings
Ff1. Targeted therapies in epithelial ovarian cancer. ESGO workshop for epithelial ovarian
cancer. 23-24 February 2007, Ankara-TURKEY
Ff2. Surgical treatment of uterine carcinosarcomas. Meeting of Turkish Society of Gynecologic
Oncology, 9 December 2006, Denizli.
Ff3. Screening in cervical cancer., Meeting of Turkish Society of Gynecologic Oncology, 2324 June 2006, Çanakkale.
Ff4. Pregnacy and HPV. Hacettepe University Alumni Meeting. 26-28 May 2006.
Ff5. Current treatment of cervical preinvasive diseases. Meeting of Turkish Society of
Gynecologic Oncology, 28 January 2006, Hatay.
Ff6. Treatment of advanced stage endometrial cancer. Hacettepe University, Gynecologic
Oncology Board, invited speaker, 2006.
Ff7. Consolidation treatment and isolated marker relapse at epithelial ovarian cancer. Hacettepe
University, CME, 1 April 2006.
Ff7. Consolidation treatment for epithelial ovarian cancer. 10. Congress of Turkish Society of
Gynecologic Oncology 19-23 April 2006, Antalya.
Ff8. The role of neoadjuvant chemotherapy in ovarian cancer. 5. National congress of
obstetrics and gynecology 16-21 May 2006.
Ff9. Comparison of surgical techniques for vulvar cancer. III. National congress of surgical
oncology 9-12 October 2005, Antalya.
Ff10. Neoadjuvat chemotherapy for epithelial ovarian cancer. Hacettepe University,
Gynecologic Oncology Board, invited speaker, 2005.
Ff11. Comparison of LEEP and CKC. III. National congress of surgical oncology, 2003,
İstanbul.
Ff12. The concept of sentinel lymph node in gynecologic oncology. Current concepts in
nuclear medicine. Hacettepe University, CME 11-12 April 2003.
Ff13. RIA in Turkey and World. 5. National congress of family planning. 19-22 april, 2007,
Ankara.
Ff14. Secondary cytoreductive surgery in ovarian cancer. Hacettepe University, Gynecologic
Oncology Board, invited speaker, 2007.
Ff15. Molecular prognostic factors. 10. Congress of Turkish Society of Gynecologic Oncology,
2008, Antalya.
Ff16. Gynecologic pain. 6. National congress of obstetrics and gynecology, 2008, Antalya.
Ff17. Laparoscopic hysterectomy. 6. National congress of obstetrics and gynecology, 2008,
Antalya.
Ff18. Molecular prevention for endometrial cancer. Cancer prevention meeting. 2008, Çeşme.
Ff19. Management of urogynecological pain. Family doctors meeting. 9-12 October, 2008,
Antalya.
Ff20. Total laparoscopic hysterectomy. Video-workshop in gynecologic oncology. 12-14
february 2009, Ankara.
Ff21. Colorectal surgery for advanced stage ovarian cancer. Meeting of Turkish Society of
Gynecologic Oncology, april 2009, Diyarbakır.
Ff22. Management of postoperative pain. 5. National congress of family planning. 23-25 april,
2009, Ankara.
Ff23. Colorectal surgery in epithelial ovarian cancer. 7. National congress of obstetrics and
gynecology, 14-19 May, 2009, Girne.
Ff24. Treatment for advanced stage cervical cancer. Meeting of Turkish Society of
Gynecologic Oncology, Adana, 2010.
Ff25. Tumor markers. Meeting of Turkish Society of Gynecologic Oncology, Gaziantep 2010.
Ff26. Borderline ovarian tumors? Meeting of Turkish Society of Gynecologic Oncology,
Manisa, 2010.
Ff27. Surgical staging in local advanced stage cervical cancer. 12. Congress of Turkish Society
of Gynecologic Oncology, 2010.
Ff28. Resection of bulky lymph nodes. 2. Videoworkshop of Turkish Society of Gynecologic
Oncology, 2011.
Ff29. Laparoscopic transperitoneal lymphadenectomy. Meeting of Robotic Surgery, İstanbul,
2011.
Ff30. Laparoscopic resection of bulky lymph nodes. AAGL-JED meeting, İstanbul, 2011.
Ff31. Restaging in epithelial ovarian cancer. 8. National congress of obstetrics and gynecology,
Antalya 2011.
Ff32. The role of Ca125 in the monitorization of Ovarian Cancer: Pro & Con. Meeting of
Turkish-German Association, 2011.
Ff33. Surgical treatment of cervical cancer. Meeting of Hacettepe University Oncology
Institute, 2011.
Ff34. Tips and tricks of laparoscopic hysterectomy. Meeting of TJOD İstanbul, 2012.
Ff35. Difficulties of laparoscopic paraaortic dissection. Meeting of Uludag University, Bursa,
2012.
Ff36. Laparoscopic management of adnexal mass. JED Workshop, 2012, İstanbul.
Ff37. Prevention of complications of laparoscopic hysterectomy. 5. Meeting of Aegian
Gynecologic Endoscopy, İzmir, 2012.
Ff38. The value of restaging for epithelial ovarian cancer. Meeting of Turkish Society of
Gynecologic Oncology, Edirne, 2012.
Ff39. Laparoscopic anatomy. Yeditepe University-JED Workshop, 2012.
Ff40. Restaging for incompletely treated ovarian cancer patients. 9. National congress of
obstetrics and gynecology, Antalya, 2012.
Ff41. LESS Hysterectomy. Developments in minimal invasive surgery III, American Hospital,
2012.
Ff42. Laparoscopic myomectomy: Technique, literature, case presentations. Laparoscopy
course at Golbasi Laparoscopic Education Center of Gazi University, Ankara 2012.
Ff43. Treatment for UPSC and clear cell tumors. 13. Congress of Turkish Society of
Gynecologic Oncology, Antalya 2012.
Ff44. Step by step resection of pelvic side wall in Wertheim surgery. 13. Congress of Turkish
Society of Gynecologic Oncology, Antalya 2012.
Ff45. Laparoscopic treatment of early stage epithelial ovarian cancer. 1. MESGE and 5.
National JED congress, 2013.
Ff46. Laparoscopic anatomy. 4.Gynecologic video-endoscopy and laparoscopic suture course,
Istanbul, 2013.
Ff47. Laparoscopic treatment of epithelial ovarian cancer, 10. National congress of obstetrics
and gynecology, Antalya 2013.
Ff48. Laparoscopic pelvic anatomy. Zeynep Kamil Meeting, Istanbul, 2013.
f-2-Lectures at International Meetings
Ff2-1. Chairmen, Radiation oncology. 1st World congress on cancer, january 12-14, 2009,
India.
Ff2-2. The role of cytoreductive surgery in advanced stage epithelial ovarian cancer. 1st World
congress on cancer, january 12-14, 2009, India.
Ff2-3. Total abdominal colectomy with ileal J-pouch-rectal anastomosis for primary
cytoreduction of ovarian cancer. International videoworkshop on radical surgery in gynecologic
oncology, Prague, 2010.
Ff2-4. Prevention of gynecologic cancer: screening and immunization. NAAMA congress,
2012, İstanbul.
Ff2-5. Retroperitoneal Advanced Laparoscopic Surgery for Gynecologic Malignancies and
Deep Pelvic Endometriosis. Professor meeting on endoscopic gynecologic surgery, Cleveland,
2013.
h-Reviewer
1. International Journal of Gynecological Cancer
2. Gynecologic Oncology
3. Indian Journal of Cancer
4. Journal of Reproductive Medicine
5. European Journal of Obstetrics Gynecology and Reproductive Biology
6. Maturitas
7. Archives of Gynecology and Obstetrics
8. Journal of Surgical Oncology
9. European Journal of Surgical Oncology
10. Annals of Oncology
Citations, h-index, i10 index-According to the Google Scholar